Pro-Dex, Inc. PDEX
63.40 USD +3.16 (+5.24%)
Nov 4, 2026, 2:39 PM EST
61.05 Day range 63.00
28.81 52-week range 77.00
- YTD
- +64.75%
- 1 year
- +87.89%
- Market cap
- 200.90M
- Revenue (ttm)
- 56.80M
- Profit margin
- 9.17%
- EPS (ttm)
- 3.63
- Shares out
- 3.26M
- P/E ratio
- 17.29
- Forward P/E
- 22.28
- YTD return
- +64.75%
- 1-year return
- +87.89%
- Volume
- 23.48K
- Avg volume
- 63.25K
- Open
- 61.26
- Previous close
- 60.24
- Day's range
- 61.05 – 63.00
- 52-week range
- 28.81 – 77.00
- Beta
- 0.39
- Price target
- 52.00 (-18.0%)
- Earnings date
- Feb 13, 2025
2Y +21.60 (+53.16%)
Key statistics
- Enterprise value
- 166.05M
- PEG ratio
- 0.00
- Price / sales
- 2.63
- Price / book
- 4.90
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 24.70%
- Free cash flow
- 6.52M
- Total cash
- 7.82M
- Total debt
- 15.01M
- Return on equity
- 16.78%
- Short % of float
- 7.29%
- 50-day average
- 41.69
- 200-day average
- 25.75
Analyst view
Price target (mean) 52.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 13, 2025
Expected Feb 13, 2025. Consensus EPS estimate 0.38.
Financials — quick view
PDEX Revenue — quarterly 20.56M
PDEX Net income — quarterly 3.05M
PDEX EPS — quarterly 0.95
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.33 | — | — | — |
| Oct 31, 2024 | Sep 1, 2024 | 0.29 | 0.75 | +0.46 | +158.62% |
| Sep 5, 2024 | Jun 1, 2024 | 0.00 | 0.46 | — | — |
| May 2, 2024 | Mar 1, 2024 | 0.00 | 0.19 | — | — |
| Feb 8, 2024 | Dec 1, 2023 | 0.00 | 0.14 | — | — |
| Nov 2, 2023 | Sep 1, 2023 | 0.00 | -0.17 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | main | Buy | Buy |
| Sep 9, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jan 4, 2017 | Ascendiant Capital | init | — | Buy |
About Pro-Dex, Inc.
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- pro-dex.com
News
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates 
Pro-Dex Q1 EPS $0.92 Beats $0.66 Estimate, Sales $20.560M Beat $20.400M Estimate 
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth? 
Pro-Dex (NASDAQ:PDEX) Stock Breaks Below Two Hundred Day Moving Average – What’s Next? 
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve 
Best Momentum Stocks to Buy for September 18th 
New Strong Buy Stocks for September 18th 
Bank of New York Mellon Corp Invests $678,000 in Pro-Dex, Inc. $PDEX 
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $74 
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on PDEX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CABILLOT RAYMOND E | Director | Stock Award(Grant) | Nov 19, 2024 | 361,846 |
| CHARLTON ALISHA K | Chief Financial Officer | Stock Award(Grant) | Nov 19, 2024 | 16,339 |
| DOMINGO ANGELITA REBAMONTAN | Director | Stock Award(Grant) | Nov 19, 2024 | 13,437 |
| FARRELL WILLIAM JAMES III | Director | Stock Award(Grant) | Nov 19, 2024 | 6,100 |
| HOVDA DAVID C | Director | Stock Award(Grant) | Nov 19, 2024 | 3,300 |
| PHILP KATRINA MARIE KRAMER | Director | Stock Award(Grant) | Nov 19, 2024 | 15,696 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.72% | 121,127 | 5.56M | Sep 29, 2024 |
| Punch & Associates Investment Management, Inc. | 2.09% | 68,000 | 3.12M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 1.93% | 63,036 | 2.89M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 1.73% | 56,345 | 2.59M | Sep 29, 2024 |
| Blackrock Inc. | 1.19% | 38,782 | 1.78M | Sep 29, 2024 |
| Northern Trust Corporation | 0.96% | 31,328 | 1.44M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.01% | 98,013 | 4.50M | Sep 29, 2024 |
| DFA U.S. Small Cap Series | 0.75% | 24,389 | 1.12M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 0.68% | 22,090 | 1.01M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.39% | 12,698 | 582.84K | Oct 30, 2024 |
| Northern Small Cap Core Fund | 0.29% | 9,343 | 428.84K | Sep 29, 2024 |
| DFA U.S. Core Equity 1 Portfolio | 0.24% | 7,945 | 364.68K | Jul 30, 2024 |